Skip to content

Released Nov 10, 2025, after the close

10-Q filed Nov 10, 2025, 41 days after period end · 0001636422-25-000146

Q3 2025 · 10-Q
Revenue$76.32M−0.0% vs Q3 2024−5.4% vs Q2 2025
Net Income-$22.23MN/M vs Q3 2024N/M vs Q2 2025
EPS Diluted-$0.32N/M vs Q3 2024N/M vs Q2 2025
Gross Profit$40,133,000+10.6%
Operating Income-$17,509,000N/M
Operating Cash Flowderived-$464,000N/M
Free Cash Flowderived-$719,000N/M
Margins · derived
Gross margin52.6%+5.1 pt vs Q3 2024
Operating margin-22.9%−5.0 pt vs Q3 2024
Net margin-29.1%−9.8 pt vs Q3 2024

What the release said

The release

Same quarter

MetricQ3 2025Q3 2024Q3 2023Q3 2022
Revenue$76.32M$76.35M$73.77M$68.35M
Net Income-$22.23M-$14.73M-$22.03M-$45.74M
EPS Diluted-$0.32-$0.24-$0.39-$0.84

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Health Catalyst, Inc. · CIK 1636422 · Engraved from SEC EDGAR